DK2976355T3 - Vaccines against chlamydia sp - Google Patents

Vaccines against chlamydia sp Download PDF

Info

Publication number
DK2976355T3
DK2976355T3 DK14721199.9T DK14721199T DK2976355T3 DK 2976355 T3 DK2976355 T3 DK 2976355T3 DK 14721199 T DK14721199 T DK 14721199T DK 2976355 T3 DK2976355 T3 DK 2976355T3
Authority
DK
Denmark
Prior art keywords
vaccines against
against chlamydia
chlamydia
vaccines
Prior art date
Application number
DK14721199.9T
Other languages
Danish (da)
English (en)
Inventor
Anja Olsen
Peter Lawætz Andersen
Frank Follmann
Ida Rosenkrands
Original Assignee
Statens Seruminstitut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Statens Seruminstitut filed Critical Statens Seruminstitut
Application granted granted Critical
Publication of DK2976355T3 publication Critical patent/DK2976355T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/118Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14721199.9T 2013-03-18 2014-03-17 Vaccines against chlamydia sp DK2976355T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201300155 2013-03-18
DKPA201300684 2013-12-11
PCT/DK2014/000015 WO2014146663A1 (en) 2013-03-18 2014-03-17 Vaccines against chlamydia sp.

Publications (1)

Publication Number Publication Date
DK2976355T3 true DK2976355T3 (en) 2020-03-30

Family

ID=50639248

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14721199.9T DK2976355T3 (en) 2013-03-18 2014-03-17 Vaccines against chlamydia sp

Country Status (20)

Country Link
US (4) US20140275478A1 (enExample)
EP (1) EP2976355B1 (enExample)
JP (3) JP2016514713A (enExample)
CN (2) CN113185587A (enExample)
AU (1) AU2014234765B2 (enExample)
BR (1) BR112015023886B1 (enExample)
CA (1) CA2907199C (enExample)
CY (1) CY1122905T1 (enExample)
DK (1) DK2976355T3 (enExample)
ES (1) ES2781579T3 (enExample)
HR (1) HRP20200511T1 (enExample)
HU (1) HUE048573T2 (enExample)
LT (1) LT2976355T (enExample)
PL (1) PL2976355T3 (enExample)
PT (1) PT2976355T (enExample)
RS (1) RS60135B1 (enExample)
RU (1) RU2723046C2 (enExample)
SI (1) SI2976355T1 (enExample)
SM (1) SMT202000160T1 (enExample)
WO (1) WO2014146663A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10688171B2 (en) 2015-02-10 2020-06-23 Ohio State Innovation Foundation Chlamydia-activated B cell platforms and methods thereof
CN104800841B (zh) * 2015-03-02 2019-04-02 中国农业科学院兰州兽医研究所 牦牛流产衣原体灭活疫苗及其制备方法
EP3274716B1 (en) 2015-03-24 2019-05-08 Universiteit Gent A method and peptides for the detection of chlamydia suis
WO2017075653A1 (en) * 2015-11-04 2017-05-11 University Of The Sunshine Coast Chlamydia antigens and uses thereof
US10835601B2 (en) 2015-11-10 2020-11-17 Ohio State Innovation Foundation Methods and compositions related to accelerated humoral affinity
NL2019320B1 (en) * 2017-03-02 2018-09-21 Biosparq B V Diagnostic method and system for diagnosis
CA3057318A1 (en) * 2017-03-23 2018-09-27 Ohio State Innovation Foundation Recombinant chlamydia-activated b cell platforms and methods of use thereof
RU2721123C1 (ru) * 2019-09-26 2020-05-18 федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи» Министерства здравоохранения Российской Федерации Штамм рекомбинантной псевдоаденовирусной частицы, экспрессирующий химерный ген MBL-CT666 Chlamydia trachomatis, способ его получения, иммуногенная композиция для защиты от урогенитального хламидиоза человека
CA3205280A1 (en) * 2020-12-23 2022-06-30 Inserm (Institut National De La Sante Et De La Recherche Medicale) Chlamydia vaccine based on targeting momp vs4 antigen to antigen presenting cells
CN116854812B (zh) * 2022-03-23 2024-09-24 东莞市朋志生物科技有限公司 抗沙眼衣原体的抗体、检测沙眼衣原体的试剂和试剂盒
CN115975049A (zh) * 2022-11-12 2023-04-18 北京成大天和生物科技有限公司 一种沙眼衣原体重组蛋白及其制备方法和应用
AR132053A1 (es) 2023-03-02 2025-05-21 Sanofi Pasteur Composiciones para su uso en el tratamiento de clamidia
WO2025104023A1 (en) 2023-11-13 2025-05-22 Ziphius Nv MODIFIED ALPHAVIRAL nsP3

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
US5869608A (en) 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
US5837268A (en) * 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
GB9215780D0 (en) * 1992-07-24 1992-09-09 Univ London Pharmacy Peptide compounds
JP3633933B2 (ja) * 1992-07-31 2005-03-30 アカンビス、リサーチ、リミテッド 弱毒化細菌における組換え融合タンパク質の発現
EP0662083A1 (en) 1992-09-18 1995-07-12 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Synthetic peptide vaccine for chlamydia trachomatis
GB9516293D0 (en) * 1995-08-09 1995-10-11 Immunova Ltee Novel peptides and their use as vaccines
JP2002512622A (ja) * 1997-05-06 2002-04-23 バンダービルト ユニバーシティー クラミジアにより引き起こされる感染の診断および管理のための抗クラミジア剤の組成物
JP2004522432A (ja) * 2000-12-22 2004-07-29 シノヴィス・リミテッド Toll関連レセプター(trr)シグナル伝達の調節方法
US7105171B2 (en) 2002-03-07 2006-09-12 The Regents Of The University Of California Porin B (PorB) as a therapeutic target for prevention and treatment of infection by Chlamydia
JP4896715B2 (ja) * 2003-06-26 2012-03-14 ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド Chlamydiatrachomatisに対する免疫原性組成物
EP1812058B1 (en) * 2004-10-25 2012-06-13 Statens Serum Institut Chlamydia trachomatis antigens for vaccine and diagnostic use
AU2006247188A1 (en) * 2005-05-18 2006-11-23 Children's Hospital & Research Center At Oakland Methods and compositions for immunizing against chlamydia infection
TW201012929A (en) * 2008-09-29 2010-04-01 Univ Nat Pingtung Sci & Tech A hybridoma cell line producing monoclonal antibodies against chalmydophila aborts
AU2010207828B2 (en) * 2009-01-29 2016-07-14 British Columbia Cancer Agency Branch Compositions comprising Chlamydia antigens
US8735543B2 (en) * 2010-05-28 2014-05-27 Spixia Biotechnology Ab Chimeric MOMP antigen
ES2670095T3 (es) * 2011-06-17 2018-05-29 Universiteit Gent Vacunas contra Chlamydia

Also Published As

Publication number Publication date
JP2021193123A (ja) 2021-12-23
EP2976355A1 (en) 2016-01-27
WO2014146663A1 (en) 2014-09-25
JP7506930B2 (ja) 2024-06-27
PL2976355T3 (pl) 2020-07-13
CN105377879A (zh) 2016-03-02
US20190099478A1 (en) 2019-04-04
CN113185587A (zh) 2021-07-30
JP2019163253A (ja) 2019-09-26
HUE048573T2 (hu) 2020-08-28
RU2015141214A (ru) 2017-04-26
AU2014234765B2 (en) 2018-01-25
CN105377879B (zh) 2021-05-04
HRP20200511T1 (hr) 2020-06-26
CA2907199A1 (en) 2014-09-25
ES2781579T3 (es) 2020-09-03
SMT202000160T1 (it) 2020-05-08
EP2976355B1 (en) 2020-01-01
BR112015023886B1 (pt) 2023-05-16
JP2016514713A (ja) 2016-05-23
AU2014234765A1 (en) 2015-10-08
US20140275478A1 (en) 2014-09-18
SI2976355T1 (sl) 2020-07-31
US10925954B2 (en) 2021-02-23
US20250255951A1 (en) 2025-08-14
US20210205433A1 (en) 2021-07-08
JP7510142B2 (ja) 2024-07-03
RS60135B1 (sr) 2020-05-29
LT2976355T (lt) 2020-04-10
PT2976355T (pt) 2020-04-02
CY1122905T1 (el) 2021-10-29
BR112015023886A2 (pt) 2017-10-24
CA2907199C (en) 2023-10-17
RU2723046C2 (ru) 2020-06-08

Similar Documents

Publication Publication Date Title
IL276210B1 (en) Mers-cov vaccine
DK3689865T3 (en) Hidtil ukendte aminopyrimidinderivater
DK3354246T3 (en) Udstyrsmonteringssystem
DK2976355T3 (en) Vaccines against chlamydia sp
PL3077519T3 (pl) Szczepionki CMV
EP2950428A4 (en) ACTUATOR
AU356420S (en) Blower
GB2510208B (en) Actuator
GB201304236D0 (en) Hand-warmer
AU353643S (en) Stamphousing
PL2958935T3 (pl) Szczepionka
GB201312869D0 (en) Actuator
GB201317144D0 (en) Elongate Member
GB201313535D0 (en) Hairdryers
GB201301617D0 (en) T-Monitor
PL2784312T3 (pl) Siłownik
GB201320646D0 (en) Vaccine
GB201315556D0 (en) Vaccine
DK2989854T3 (en) Strømstyret opvarmningssystem
GB201320421D0 (en) Conjugated vaccine
GB201307873D0 (en) Retaining device
GB201318389D0 (en) Actuator
GB201318451D0 (en) W/C Sani-vent
GB201310308D0 (en) Damage limitation
GB201304119D0 (en) Hairdryers